---
title: "Maharashtra FDA Suspends 10 Ayurvedic Drug Makers for Serious Violations"
url: https://projectchintan.com/article/maharashtra-fda-suspends-10-ayurvedic-drug-makers-hlmio
publisher: Project Chintan
author: Project Chintan Newsroom
section: Health
published: 2026-08-13T03:30:34.270Z
modified: 2026-08-13T05:30:06.443Z
language: en-IN
---

# Maharashtra FDA Suspends 10 Ayurvedic Drug Makers for Serious Violations

The Maharashtra Food and Drug Administration (FDA) has cancelled the licences of 10 Ayurvedic drug manufacturers following inspections that revealed serious violations. The agency also issued show-cause notices to 135 other firms for non-compliance with regulations.

## Key takeaways

- The Maharashtra FDA has cancelled the licences of 10 Ayurvedic drug manufacturers.
- Inspections revealed serious violations including unhygienic conditions and lack of technical staff.
- 135 other manufacturers received show-cause notices for non-compliance.
- The FDA is enforcing quality standards and Good Manufacturing Practices for Ayurvedic medicines.
- Actions are being taken to protect public health and ensure drug safety and efficacy.

The Maharashtra Food and Drug Administration (FDA) has taken action against 10 manufacturers of Ayurvedic medicines by cancelling their operational licences. This decision follows an extensive inspection of 434 licensed Ayurvedic drug manufacturing units across the state.

## What Happened

During a state-wide inspection drive, FDA officials identified significant violations at multiple facilities. These included unhygienic premises, a lack of qualified technical staff, and inadequate protocols for testing raw materials. In response to these findings, the FDA has cancelled the licences of 10 companies and issued show-cause notices to an additional 135 manufacturers, requiring them to provide explanations for the observed deficiencies.

## Key Facts

- The Maharashtra FDA inspected 434 licensed Ayurvedic drug manufacturing units.
- Licences of 10 manufacturers were cancelled due to serious violations.
- 135 firms received show-cause notices for non-compliance.
- Violations included unhygienic conditions, absence of technical staff, and inadequate raw material testing.
- The FDA Commissioner, Tukaram Mundhe, stated that strict action would be taken against non-compliant manufacturers.
- Inspections covered compliance with the Drugs and Cosmetics Act, Rules, and Good Manufacturing Practices (GMP) under Schedule T.
- Specific deficiencies noted included lack of qualified personnel, non-functional quality control, missing machinery, incorrect labelling, and failure to prevent cross-contamination.
- The FDA stated these deficiencies pose risks to the quality, safety, and efficacy of medicines and public health.
- The FDA has been conducting raids on various food establishments.

## Background

The FDA's actions are aimed at ensuring that Ayurvedic medicines are produced according to established standards, including those outlined in recognized reference books for classical medicines and quality standards for patent and proprietary medicines. The inspections assessed manufacturing premises, technical manpower, quality control, batch records, and testing procedures, among other aspects.

---
Canonical: https://projectchintan.com/article/maharashtra-fda-suspends-10-ayurvedic-drug-makers-hlmio
Reported from: Multiple Sources